2017年，珠海岐微生物科技股份有限公司在横琴注册，成为首批入驻园区的医药企业之一。公司主要针对全球尚无有效药物的眼科重大疾病——干性老年黄斑变性，开发创新中药和小分子化学药品。目前，公司的创新中药QA108在国内已进入Ⅲ期临床试验。公司首席技术官欧阳晖说：“关于老年黄斑变性致病机理研究的论文已在国际医学杂志上发表，为新药问世奠定了坚实基础。这款新药将填补全球空白，造福更多老年黄斑变性患者。”
以色列：以色列總理內塔尼亞胡視察伊朗彈道飛彈襲擊現場，該襲擊造成九名以色列人死亡。他向媒體表示，若伊朗獲得核武器，將會威脅「全人類」。
，更多细节参见heLLoword翻译官方下载
“We’ve been very involved from neighbor alerts, community alerts that go through our network,” he said.，详情可参考体育直播
Опубликованы фото роскошных бункеров ДубаяDaily Mail публикует фото роскошных бункеров Дубая на фоне воздушных атак Ирана
As such, OpenAI's swift DOW deal provoked immediate backlash from its civilian users. Despite OpenAI's claim that its deal has even more safeguards than Anthropic's original agreement, the contract appeared to allow for both mass surveillance and AI-controlled weapons as long as such use is legal, and even laid out circumstances in which it would be permitted.